Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute group A streptococcal pharyngotonsillitis

References

• Stjernquist-Desatnik A, Prellner K, Christensen P. Clinical and laboratory findings in patients with acute tonsillitis. Acta Otolaryngol (Stockholm) 1987; 104: 351–9
   PubMed Web of Science ®Google Scholar
• Schwartz R, Wientzen R, Pedreira F, Feroli EJ, Mella GW, Guandolo UL. Penicillin V for group A streptococcal pharyngotonsillitis. JAMA 1981; 246: 1790–5
   PubMed Web of Science ®Google Scholar
• Orrling A, Stjernquist-Desatnik A, Schalén C, Kamme C. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Scand J Infect Dis 1994; 26: 535–41
   PubMed Web of Science ®Google Scholar
• Orrling A, Stjernquist-Desatnik A, Schalén C. Clindamycin in recurrent group A streptococcal pharyngotonsillitis: an alternative to tonsillectomy?. Acta Otolaryngol (Stockholm) 1997; 117: 618–22
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Johnson DR. Clinical and laboratory observations: eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. The Journal of Pediatrics 1988; 113: 400–3
   PubMed Web of Science ®Google Scholar
• Brook I. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococci. Pediatr Infect Dis 1985; 4: 491–5
   PubMedGoogle Scholar
• Pichichero ME, Disney FA, Aronovitz GH, Talpey WB, Green JL, Francis AB. Randomized, single-blind evaluation of cefadroxil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis. Antimicrobial Agents and Chemotherapy 1987; 31: 903–6
   PubMedGoogle Scholar
• Sanders C, Sanders E, Harrow D. Bacterial interference: effects of oral antibiotics on the normal throat flora and their ability to interfere with a group A streptococci. Infect Immun 1976; 13: 808–12
   PubMed Web of Science ®Google Scholar
• Roos K, Grahn E, Holm SE, Johansson H, Lind L. Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otorhinolaryngol 1993; 25: 141–8
   PubMed Web of Science ®Google Scholar
• Kim KS, Kaplan EL. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr 1985; 107: 681–4
   PubMed Web of Science ®Google Scholar
• Orrling A, Stjernquist-Desatnik A, Schalén C, Kamme C. Treatment failure in streptococcal pharyngotonsillitis. An attempt to identify penicillin tolerant Streptococcus pyogenes. Scand J Infect Dis 1996; 28: 143–7
   PubMed Web of Science ®Google Scholar
• La Penta D, Rubens C, Chi E, Cleary P. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci USA 1994; 91: 12115–9
   PubMed Web of Science ®Google Scholar
• Österlund A, Popa R, Nikkilä T, Scheynius A, Engstrand L. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. The Laryngoscope 1997; 107: 640–7
   PubMed Web of Science ®Google Scholar
• Österlund A, Engstrand L. An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium: studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol (Stockholm) 1997; 117: 883–8
   PubMed Web of Science ®Google Scholar
• Österlund A, Engstrand L. DNA fingerprinting of Streptococcus pyogenes from patients with recurrent pharyngotonsillitis by means of random amplified polymorphic DNA analysis. Scand J Infect Dis 1995; 27: 119–21
   PubMed Web of Science ®Google Scholar
• Orrling A, Melhus Å, Karlsson E, Stjernquist-Desatnik A. Penicillin treatment failure in group A streptococcal tonsillopharyngitis: no genetic difference found between strains isolated from failures and non-failures. Annals of Otology. Rhinology & Laryngology 2001; 110: 690–5
   PubMed Web of Science ®Google Scholar
• Ebenfelt A, Lundberg C. Bacterial invasion of the tonsillar tissues in acute pharyngotonsillitis and in the adenoid: a preliminary study. Clin Otolaryngol 1994; 19: 310–3
   PubMed Web of Science ®Google Scholar
• Strömberg A, Friberg U, Cars O. Concentrations of phenoxymethylpenicillin and cefadroxil in tonsillar tissue and tonsillar surface fluid. European Journal of Clinical Microbiology 1987; 6: 525–9
   PubMedGoogle Scholar
• Stjernquist-Desatnik A, Samuelsson P, Walder M. Penetration of penicillin V tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. Laryngol Otol 1993; 107: 309–12
   PubMed Web of Science ®Google Scholar
• Jensen JH, Larsen SB. Treatment of recurrent acute tonsillitis with clindamycin: an alternative to tonsillectomy?. Clin Otolaryngol 1991; 16: 498–500
   PubMedGoogle Scholar
• Price CP, Spencer K, Whicher J. Light scattering immunoassay of specific proteins: a review. Ann Clin Biochem 1983; 20: 1–14
   PubMed Web of Science ®Google Scholar
• Svendsen PJ, Blirup-Jensen S. Determination of human plasma proteins by turbidimetry and nephelometry. Dako, Copenhagen 1991
   Google Scholar
• Kamme C, Petersson A-C. In vitro effect on group A streptococci of loracarbef versus cefadroxil, cefaclor and penicillin V. Scand J Infect Dis 1993; 25: 37–42
   PubMedGoogle Scholar
• Kataja, J, Huovinen, P, Skurnik, M, The Finnish study group for antimicrobial resistance, Seppälä H. Erythromycin resistance genes in group A streptococci in Finland. Antimicrobial Agents and Chemotherapy 1999;43:48–52.
   PubMed Web of Science ®Google Scholar
• Cohen R, Reinert P, De La Rocque F, Levy C, Boucherat M, Robert M, et al. Comparison of 2 dosages of azithromycin for 3 d vs penicillin V for 10 d in acute group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2002; 21: 297–303
   PubMed Web of Science ®Google Scholar
• Brook I, Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to group A beta-haemolytic streptococci. Clinical Pediatrics 1985; 24: 331–6
   PubMed Web of Science ®Google Scholar
• Watkins VS, Smietana M, Conforti PM, Sides GD, Huck W. Comparison of dirithromycin and penicillin for treatment of streptococcal pharyngitis. Antimicrobial Agents and Chemotherapy 1997; 41: 72–5
   PubMedGoogle Scholar
• Strömberg A, Schwan A, Cars O. Five versus 10 d treatment of group A streptococcal pharyngotonsillitis randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis 1988; 20: 37–46
   PubMed Web of Science ®Google Scholar
• Roos K, Larsson P. Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis. Scand J Infect Dis 1997; 29: 141–5
   PubMed Web of Science ®Google Scholar
• Tulkens PM. Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections. Scand J Infect Dis Suppl 1991; 74: 209–17
   Google Scholar
• Eli Lilly & Co, MSDS: Loracarbef monohydrate.
   Google Scholar
• Stevens D, Gibbons A, Bergström R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988; 158: 23–8
   PubMed Web of Science ®Google Scholar